Multiplexed immunolabelling of cancer using bioconjugated plasmonic gold-silver alloy nanoparticles.

Reliable protein detection methods are vital for advancing biological research and medical diagnostics. While immunohistochemistry and immunofluorescence are commonly employed, their limitations underscore the necessity for alternative approaches. This study introduces immunoplasmonic labelling, utilizing plasmonic nanoparticles (NPs), specifically designed gold and gold-silver alloy NPs (Au:Ag NPs), for multiplexed and quantitative protein detection.

Dynamic multispectral detection of bacteria with nanoplasmonic markers.

Culture-based diagnosis of bacterial diseases is a time-consuming technique that can lead not only to antibiotic resistance or bacterial mutation but also to fast-spreading diseases. Such mutations contribute to the fast deterioration of the patient's health and in some cases the death depending on the complexity of the infection. There is great interest in developing widely available molecular-level diagnostics that provide accurate and rapid diagnosis at the individual level and that do not require sophisticated analysis or expensive equipment.

Porous Au-Ag Nanoparticles from Galvanic Replacement Applied as Single-Particle SERS Probe for Quantitative Monitoring.

Plasmonic nanostructures have raised the interest of biomedical applications of surface-enhanced Raman scattering (SERS). To improve the enhancement and produce sensitive SERS probes, porous Au-Ag alloy nanoparticles (NPs) are synthesized by dealloying Au-Ag alloy NP-precursors with Au or Ag core in aqueous colloidal environment through galvanic replacement reaction. The novel designed core-shell Au-Ag alloy NP-precursors facilitate controllable synthesis of porous nanostructure, and dealloying degree during the reaction has significant effect on structural and spectral properties of dealloyed porous NPs.

Multiplexed Plasmonic Nano-Labeling for Bioimaging of Cytological Stained Samples.

Reliable cytopathological diagnosis requires new methods and approaches for the rapid and accurate determination of all cell types. This is especially important when the number of cells is limited, such as in the cytological samples of fine-needle biopsy. Immunoplasmonic-multiplexed- labeling may be one of the emerging solutions to such problems.